Reports

231 Results (Page 1 of 10)

Canada Markets Research Reports

Pharmaceuticals

Canada Dermatological Therapeutics Market Analysis

Canada Dermatological Therapeutics Market is at around $3.28 Bn in 2023 and is projected to reach $5.84 Bn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The market is growing due to factors such as the rising prevalence of skin disorders, the aging population, and technological developments. The market is dominated by key players like Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Cardiovascular Drugs Market Analysis

Canada Cardiovascular Drug Market is at around $11.1 Bn in 2022 and is projected to reach $14.91 Bn in 2030, exhibiting a CAGR of 3.8% during the forecast period. One major factor propelling the market’s expansion is personalized medicine. It utilizes a patient's genetic and molecular profile to customize treatment. The market is dominated by key players like Bristol-Myers Squibb Canada Co, Pfizer Canada, Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca Canada Inc., Sanofi-Aventis Canada Inc., Novartis Pharmaceuticals Canada, Merck & Co., Inc., Gilead Sciences Canada, Inc., and F. Hoffman-La Roche Ltd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Alopecia (Hair Loss) Therapeutics Market Analysis

The Canada Alopecia (Hair Loss) Therapeutics Market was valued at US $0.65 Bn in 2022, and is predicted to grow at (CAGR) of 7.50% from 2023 to 2030, to US $1.17 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of Alopecia (hair loss), improved treatment options. The industry is primarily dominated by players such as Eli Lilly, Pfizer, Allergan, Valeant, Bayer, Roche, AbbVie among others.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Digital Health

Canada Digital Therapeutics Market Analysis

Canada Digital Therapeutics Market is at around $0.5 Bn in 2023 and is projected to reach $2.7 Bn in 2030, exhibiting a CAGR of 27.2% during the forecast period. The industry is being driven by advancements in technology, government support and regulations, and growing awareness. The market is dominated by key players like Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., HYGIEIA, BigHealth, and Voluntis.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Allergy Therapeutics Market Analysis

Canada Allergy Therapeutics Market was valued at $1856 Mn in 2022 and is estimated to reach $3049 Mn in 2030, exhibiting a CAGR of 6.4% during the forecast period. The rising incidence of allergic diseases and associated illnesses is a major market driver for the expansion of the allergy therapeutics market. Some of the leading pharmaceutical companies operating in the market are Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló, and Stallergenes Greer

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Age-Related Macular Degeneration Therapeutics Market Analysis

The Canada Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $0.86 Bn in 2022, and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to US $1.71 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, advancements in diagnostic technologies, and other factors. The industry is primarily dominated by players such as Genentech, Novartis, Bayer, Roche, and Ocular Therapeutics, among others

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Alcohol Addiction Therapeutics Market Analysis

The Canada Alcohol Addiction Therapeutics Market is valued at around $57 Mn in 2022 and is projected to reach $93 Mn by 2030, exhibiting a CAGR of 6.3% during the forecast period. The Increasing public awareness, government support, and advancements in research and innovation are driving the destigmatization of alcohol addiction, fostering greater acceptance of mental health, and fueling the demand for more accessible and personalized treatment options, thus increasing market growth. The key players involved in the research, development, and distribution of alcohol addiction therapeutics in Canada are AbbVie, AstraZeneca, Roche, Bausch Health, Pfizer, Otsuka, Alkermes, Ethypharm, Biovail, Beacon etc among others.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis

The Canada Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $264 Mn in 2022 and is predicted to grow at a CAGR of 7.8% from 2023 to 2030, to US $481 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of acute lymphocytic leukaemia cases, advancements in molecular biology and pharmacology technologies, and other factors. The industry is primarily dominated by players such as Pfizer, Sanofi, Novartis, Genmab among others.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis

The Canada Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $88 Mn in 2022, and is predicted to grow at (CAGR) of 5.8% from 2023 to 2030, to US $138 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, the aging population, novel therapeutics, and other factors. The industry is primarily dominated by players such as Pfizer, Sanofi, Novartis, and Teva Pharmaceutical, among others

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Addiction Therapeutics Market Analysis

Canada addiction therapeutics market was valued at $808 Mn in 2022 and is estimated to reach $1378 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. One of the key elements driving development in the addiction therapeutics market is increase in drug awareness campaigns and addiction & rehab centres among the population. Leading key players functioning in the market include Alkremes, Teva Pharmaceutical Industries, Glenmark Pharmaceuticals, Titan Pharmaceuticals, Pfizer, Inc., GSK, Johnson & Johnson, Perrigo, Cipla, Hikma Pharmaceuticals, Dr. Reddy’s Laboratories Limited, Indivior, and Mylan N.V

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Actinic Keratosis Therapeutic Market Analysis

Canada actinic keratosis therapeutic market is anticipated to experience growth from $544 Mn in 2022 to $798 Mn by 2030, with a CAGR of 4.9% during the forecast period of 2022-2030. This market is driven by the rising prevalence of the condition supported by favourable reimbursement policies and the growing demand for minimally invasive procedures due to the advancements in technology. The market exhibits a moderate concentration due to the presence of key players such as Leo Pharma, Cipher Pharmaceuticals, 3M Canada, Valeant Pharmaceuticals, Sun Pharmaceuticals, Biofrontera, Bausch Health, among others.

PUBLISHED: Jan, 2024 | FORMAT: PPT | LAST UPDATED: Jan, 2024 | PRICE: $3999

Pharmaceuticals

Canada Sleep Disorders Market Analysis

This report presents a strategic analysis of the Canada Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Sleep Disorders Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Canada Pain Management Devices Market Analysis

This report presents a strategic analysis of the Canada Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Pain Management Devices Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Canada Oncology Drugs Market Analysis

By 2030, it is anticipated that the Canadian oncology drugs market will reach a value of $46 Mn from $15.7 Mn in 2022. The Canadian oncology drugs market would likely grow at a CAGR of 11.6% during 2022-30. The companies operating in the oncology drug in Canada market are AstraZeneca Plc. GlaxoSmithKline, Eli Lilly & Co., Roche Diagnostics, Novartis AG, Pfizer Inc., Merck & Co., Gilead, Sanofi S.A, and Celgene Corporation. The Canadian oncology drugs market is segmented based on therapy modality and types of cancer. Key factors for market growth in the oncology market can be the high rise in cancer cases, increasing research on the oncology sectors, and so on.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Clinical Trials

Canada Oncology Clinical Trials Market Analysis

This report presents a strategic analysis of the Canada Oncology Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Oncology Clinical Trials Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Canada Lung Cancer Therapeutics Market Analysis

Canada's lung cancer therapeutics market is likely to grow at a CAGR of 8.11% from a market size of $2.34 Bn in 2022 to $4.44 Bn in 2030. One of the main factors propelling the growth of the lung cancer treatments market is the increase in the adoption of unhealthy lifestyles, such as smoking. Lung cancer is known to be frequently caused by cigarette smoking. This report is segmented by type, therapy, type of molecule, drug class, and distribution channel. Some key players in this market include Sanofi, Bristol-Myers & Squibb, Pfizer, AstraZeneca, Celgene Corporation, Boehringer Ingelheim, J&J, and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Canada Lung Cancer Drugs Market Analysis

Canada's Lung Cancer Drug Market is projected to grow from $0.765 Bn in 2022 to $1.447 Bn by 2030, registering a CAGR of 8.3% during the forecast period of 2022–30. The use of personalized medicine, which tailors treatment to the specific characteristics of a patient's cancer, is also driving growth in the lung cancer drug market in Canada. Key players in the market include Pfizer, AstraZeneca, Novartis, and Bristol-Myers Squibb.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Canada Infectious Disease Therapeutics Market Analysis

Canada's infectious disease therapeutics market is likely to grow at a CAGR of 4.35% from a market size of $9.59 Bn in 2022 to $13.48 Bn in 2030. The increase in the prevalence of infectious diseases in Canada and the increasing government initiatives to provide facilities to patients have acted as a market growth driver. This report is segmented by mode of treatment, applications, disease type, target organisms, and end user. Some key players in this market include Novartis, Roche, Janssen Pharmaceutical, Merck, BI, and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Canada ECG Equipments Market Analysis

This report presents a strategic analysis of the Canada ECG Equipments Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada ECG Equipment Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Canada Diabetes Drugs Market Analysis

Canada's diabetes drugs market size was valued at $4.94 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030 and will reach $7.93 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Canadian diabetes drug market will grow as the Canadian population continues to age, and the incidence of diabetes is expected to increase. The key market players are Insulet Corporation, Sanofi, Johnson & Johnson, Abbott, Bayer Pharmaceuticals, Novo Nordisk, and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Canada Diabetes Devices Market Analysis

This report presents a strategic analysis of the Canada Diabetes Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Diabetes Devices Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Canada Depression Therapeutics Market Analysis

This report presents a strategic analysis of the Canada Depression Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Depression Therapeutics Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Clinical Trials

Canada Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis

This report presents a strategic analysis of the Canada Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Canada Cardiac Surgery Instruments Market Analysis

This report presents a strategic analysis of the Canada Cardiac Surgery Instruments Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Cardiac Surgery Instruments Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Clinical Trials

Canada COVID-19 Clinical Trials Market Analysis

This report presents a strategic analysis of the Canadian COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canadian COVID-19 Clinical Trials Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

subscribe to our newsletter
up